Dilated Cardiomyopathy Market Report

Dilated Cardiomyopathy Market Analysis, Market Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2014 To 2020

Format: PDF  |  Report ID: 469

Dilated cardiomyopathy (DCM) is a cardiac disorder caused by enlargement of heart. The muscular walls of the heart become weak due to enlargement and hence heart is not able to pump blood efficiently. The disorder causes effect on liver, lungs and other important organs of the body steadily.  It is the clinical condition which causes enlargement of initially left vertical of the heart, which is considered as main pumping chamber. Significantly, if may spread to right chamber over the time. DCM also leads to frequent blood clots, irregular heartbeats and valve problems, which may affect any person irrespective of age and sex, although the probability ratio of male over female is 3:1.

Various treatments available for DCM focuses in improvement of blood flow which is it underlying cause. The treatment of the DCM can be done with two techniques one is by oral drugand other is implantable devices. The types of DCM drugs available are beta blockers, diuretics, digitalis, angiotensin 2 receptor blocker, warfarin, diuretics and angiotensin-converting enzyme inhibitors.  In the second category of treatment, implantable devices, heart pumps and cardioverter-defibrillators are prominently used. 

The main causes of DCM are infections in cardiac muscles, genetics or birth defects, drug or alcohol abuse or certain exposure to toxic substances such as mercury, lead or cobalt. In some of the cases DCM may also be caused as side effect of cancer medication.

DCM is most common in 20 to 60 years of children. The major symptoms of DCM are frequent shortness of breath and fatigue and swelling on lower extremities, sudden gaining of weight, sudden fainting, dizziness, blood clots and chest pain.

Increase in life expectancy of individuals and prominent increase in number of heart problems over the years are prominent for development of DCM market. Whereas, increase in health awareness in the people is one of the biggest restraint for the growth of the market.

The geographical market segment of the market of the dilated cardiomyopathy is divided into four parts namely North America, Europe, Asia-Pacific and Row. Asia-Pacific and North America are expected to be growth leader of DCM market due to increase in number of heart diseases over the years. Europe with high medical infrastructure has large market but growth prospects are less. Row is expected to remain another prominent market.

The main market players involved in the treatment of DCM with manufacturing of drugs or devices are ZensunSci& tech, Capricor Therapeutics, Aastrom Biosciences, t2cure GmbH, MyoKardia and Kasiak Research pvt.ltd.

Key questions answered by the report
Request for Customization

Choose License Type:

Single User - $4,950
Multi User - $7,950
Enterprise User - $9,950

Special Pricing & Discounts

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA